2. Academic Validation
  3. Novel nonsteroidal steroid sulfatase inhibitors containing glutamic acid unit

Novel nonsteroidal steroid sulfatase inhibitors containing glutamic acid unit

  • Eur J Med Chem. 2025 Jul 5:291:117627. doi: 10.1016/j.ejmech.2025.117627.
Olga Ciupak 1,  Sebastian Demkowicz 2,  Janusz Rachon 2,  Karol Biernacki 2,  Paweł Czubak 3,  Aleksandra Martyna 3,  Maciej Masłyk 3,  Konrad Kubiński 3,  Magdalena Datta 4,  Janusz Rak 4,  Mateusz Daśko 5
Affiliations

Affiliations

  • 1 Department of Organic Chemistry, Faculty of Chemistry, Gdansk University of Technology, Narutowicza 11/12, 80-233, Gdansk, Poland. Electronic address: olga.ciupak@pg.edu.pl.
  • 2 Department of Organic Chemistry, Faculty of Chemistry, Gdansk University of Technology, Narutowicza 11/12, 80-233, Gdansk, Poland.
  • 3 Department of Molecular Biology, Faculty of Medicine, The John Paul II Catholic University of Lublin, Konstantynów 1i, 20-708, Lublin, Poland.
  • 4 Laboratory of Biological Sensitizers, Department of Physical Chemistry, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308, Gdańsk, Poland.
  • 5 Department of Inorganic Chemistry, Faculty of Chemistry, Gdansk University of Technology, Narutowicza 11/12, 80-233, Gdansk, Poland. Electronic address: mateusz.dasko@pg.edu.pl.
PMID: 40245821 DOI: 10.1016/j.ejmech.2025.117627
Abstract

In the present work, we designed and successfully synthesized novel Steroid Sulfatase (STS) inhibitors based on coumarin, tyramine, triazole, and flavone cores with an additional glutamic acid residue in the structure. The molecular modeling studies revealed that designed derivatives have potential to bind to the molecular target active site, at least theoretically. The biological activity of synthesized compounds was evaluated under a two-step procedure including enzymatic assay and cellular studies using human choriocarcinoma JEG-3 cells. Among the synthesized compounds, the derivative 54E was the most active in both enzymatic and cellular experiments. This result agreed with the molecular modeling data, which indicated that derivative 54E demonstrates the highest affinity to the STS active site. In the enzymatic assay, the remaining STS activity values of 12.97, 17.58, and 20.52 % were observed at 10, 1, and 0.1 μM concentrations of compound 54E, respectively. The IC50 value of 22 nM determined in an experiment with JEG-3 cells for compound 54E was close to the IC50 value determined for the reference STS inhibitor Irosustat (2.7 nM). During the evaluation of the uptake mechanism of the compound 54E, we found that organic anion transporting polypeptides (OATPs) may be responsible for its internalization into the cells. Furthermore, the incubation of zebrafish larvae with the compound 54E revealed no detectable toxic effects in vivo indicating that the compound 54E is a very promising candidate for further preclinical investigations.

Keywords

Cancer; Molecular docking; STS inhibitors; Steroid sulfatase; Triazole.

Figures
Products